Swedbank Ab Royalty Pharma PLC Transaction History

Swedbank Ab

$77.1 Billion
Q3 2024

A detailed history of Swedbank Ab transactions in Royalty Pharma PLC stock. As of the latest transaction made, Swedbank Ab holds 11,027,370 shares of RPRX stock, worth $275 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

11,027,370

Previous 10,813,470 1.98%

Holding current value

$275 Million

Previous $285 Million 9.4%

% of portfolio

0.4%

Previous 0.39%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$25.63 - $29.27 $5.48 Million - $6.26 Million	213,900 Added 1.98%	11,027,370 $312 Million
Q2 2024 Jul 18, 2024	BUY	$26.26 - $29.9 $284 Million - $323 Million	10,813,470 New	10,813,470 $285 Million
Q1 2024 May 14, 2024	BUY	$27.46 - $31.33 $227 Million - $259 Million	8,279,900 New	8,279,900 $251 Million
Q4 2023 Dec 09, 2024	BUY	$26.21 - $29.22 $39.8 Million - $44.3 Million	1,517,000 Added 38.39%	5,468,900 $154 Million
Q3 2023 Dec 09, 2024	BUY	$26.26 - $31.38 $2.67 Million - $3.19 Million	101,800 Added 2.64%	3,951,900 $107 Million
Q2 2023 Dec 09, 2024	BUY	$29.6 - $36.56 $23.5 Million - $29.1 Million	795,155 Added 26.03%	3,850,100 $118 Million
Q1 2023 Dec 09, 2024	BUY	$32.77 - $39.4 $39.8 Million - $47.9 Million	1,215,528 Added 66.08%	3,054,945 $110 Million
Q4 2022 Dec 09, 2024	BUY	$39.17 - $44.04 $17.6 Million - $19.8 Million	448,500 Added 32.24%	1,839,417 $72.7 Million
Q3 2022 Dec 09, 2024	BUY	$39.88 - $44.65 $35.8 Million - $40.1 Million	897,400 Added 181.84%	1,390,917 $55.9 Million
Q3 2021 Dec 09, 2024	BUY	$36.14 - $42.24 $6 Million - $7.01 Million	166,017 Added 50.69%	493,517 $17.8 Million
Q2 2021 Dec 09, 2024	BUY	$39.85 - $46.63 $13.1 Million - $15.3 Million	327,500 New	327,500 $13.4 Million

Others Institutions Holding RPRX

# of Institutions

413

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.9B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.

Account